In 2025, the Vietnam industry revenue reflected USD 2.92 billion.
By 2033, the Vietnam Infusion Services Market is anticipated to be worth USD 16.45 billion, growing at a CAGR of 24.1% during the projection period.
Private healthcare investment is accelerating oncology infrastructure build-out, strengthening infusion service density in Hanoi and Ho Chi Minh City.
Ministry of Health cancer incidence figures indicate upward diagnostic trends, sustaining forward demand for systemic therapy administration.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]